BI-CYCLIC PYRIMIDINE INHIBITORS OF TGF BETA

Compounds in which a pyrimidine nucleus is bridged at the 5 and 6 position and are further substituted at positions 2 and 4 with substituents comprising aromatic moieties are useful in treating subjects with rheumatoid arthritis ameliorated by inhibition of TGFbeta activity.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MCENROE, GLENN, CHAKRAVARTY, SARVAJIT, DUGAR, SUNDEEP, AXON, JONATHAN, CONTE, AURELIA
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Compounds in which a pyrimidine nucleus is bridged at the 5 and 6 position and are further substituted at positions 2 and 4 with substituents comprising aromatic moieties are useful in treating subjects with rheumatoid arthritis ameliorated by inhibition of TGFbeta activity.